As pressure mounts from analysts and politicians, will the Federal Reserve finally cut interest rates? With mixed economic signals and a possible dovish shift, the September meeting could be pivotal!
In a surprising move, AI startup Perplexity has offered $34.5 billion to acquire Google’s Chrome browser, aiming to preempt potential antitrust actions. This follows rival OpenAI's similar interest in the web giant's flagship product.
Apple is set to launch a new affordable MacBook starting at just $599, featuring the A18 Pro chip and a compact 12.9-inch display. Anticipated for late 2025 or early 2026, this budget-friendly laptop aims to compete with Chromebooks and boost Apple’s sales significantly.
Former Surgeon General Dr. Jerome Adams warns that the U.S. risks lives by cutting funding for mRNA vaccine research, following Secretary Kennedy's controversial decision to halt key projects.
Discover the alarming truth about popular apps that are collecting more personal data than you might think! From Google Chrome to TikTok, find out how your data is being used and what alternatives you can consider.
Amy Schumer shares her experience with back surgery and recovery on Instagram, showcasing her new walker and keeping her humor alive after the procedure. Find out more about her health journey!
A top Federal Reserve official advocates for interest rate cuts after a disappointing jobs report, raising concerns about inflation and economic stability. Will the Fed act to boost the economy?
As summer wraps up, it's time to find the perfect laptop for students. Discover top picks, essential specs, and budget-friendly options that will last throughout the school years. Don't miss out on our expert recommendations!
Perplexity's new browser, Comet, promises a unique browsing experience with integrated AI features. But does it live up to the expectations? Discover the pros and cons in our in-depth review.
A groundbreaking study reveals how 'zombie' endothelial cells may drive long-COVID and ME/CFS symptoms, linking chronic fatigue and immune dysfunction in a new narrative.